logo

For the Inventor, By the Inventor

Coubron, France

Valerie Rognon

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2003-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valerie Rognon. Retrieved from https://idiyas.com/inventor/valerie-rognon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal2 out of 377 
 
Aventis Pharma S.a.
 patents

Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6946459 - CRYSTALLINE FORMS OF 1S-[1ALPHA(2S*,3R*), 9ALPHA]6, 10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9[[(1-ISOQUINOLYL) CARBONYL]AMINO]OCTAHYDRO-6H-PIRIDAZINO[1,2-A][1,2]DIAZEPIN-1-CARBOXAMIDE (2005-09-20),
2. 6544977 - CRYSTALLINE FORMS OF 1S-[1-ALPHA(2S*,3R*), 9ALPHA]6, 10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9[[(1-ISOQUINOLYL)CARBONYL]AMINO]OCTAHYDRO-6H-PYRIDAZINO [1,2-A] [1,2] DIAZEPIN-1-CARBOXAMIDE (2003-04-08),

Title: Valerie Rognon: Innovator in Pharmaceutical Chemistry

Introduction

Valerie Rognon is a prominent inventor in the field of pharmaceutical chemistry, known for her significant contributions to the development of new crystalline forms of complex compounds. Based in Coubron, France, she has made notable advancements that enhance the efficacy and stability of pharmaceutical formulations.

Latest Patents

Valerie Rognon holds 2 patents, with her latest inventions focusing on crystalline forms of a specific compound. Her patents include "CRYSTALLINE FORMS OF 1S-[1ALPHA(2S*,3R*), 9ALPHA]6, 10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9[[(1-ISOQUINOLYL) CARBONYL]AMINO]OCTAHYDRO-6H-PIRIDAZINO[1,2-A][1,2]DIAZEPIN-1-CARBOXAMIDE" and "CRYSTALLINE FORMS OF 1S-[1-ALPHA(2S*,3R*), 9ALPHA]6, 10-DIOXO-N-(2-ETHOXY-5-OXO-TETRAHYDRO-3-FURANYL)-9[[[1-ISOQUINOLYL)CARBONYL]AMINO]OCTAHYDRO-6H-PYRIDAZINO[1,2-A][1,2]DIAZEPIN-1-CARBOXAMIDE". These patents detail the preparation processes and pharmaceutical compositions containing these new crystalline forms, which can be either anhydrous or hydrated.

Career Highlights

Valerie Rognon has built a successful career at Aventis Pharma S.A., where she has been instrumental in advancing pharmaceutical research and development. Her work has contributed to the creation of innovative drug formulations that address various medical needs.

Collaborations

Throughout her career, Valerie has collaborated with esteemed colleagues, including Jean-Yves Godard, to further enhance her research and development efforts.

Conclusion

Valerie Rognon exemplifies the spirit of innovation in pharmaceutical chemistry through her groundbreaking patents and collaborative efforts. Her contributions continue to impact the field positively, paving the way for future

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…